ASHG 2019
Recent articles
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Explore more from The Transmitter
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.